NGS-Based RNA-Sequencing Markett By Emerging Trends, Business Strategies, Technologies,and Opportunities
NGS-Based RNA-Sequencing Market business report introduces the basics of industry such as market definitions, classifications, applications and industry chain overview, after which it covers industry policies and plans, product specifications, manufacturing processes, cost structures and so on. This market document has a chapter on the global market and all its associated companies with their profiles, which provides valuable data related to their outlook in terms of finances, product portfolios, investment plans, and marketing and business strategies. The significant NGS-Based RNA-Sequencing Market report presents data on patterns and improvements, and target business sectors and materials, limits and advancements.
Data Bridge Market Research analyses that the NGS-based RNA-sequencing market which was USD 2.44 billion in 2021, would rocket up to USD 10.42 billion by 2029, and is expected to undergo a CAGR of 19.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
NGS-based RNA-seq is widely employed for sophisticated and comprehensive genomic insights in both standard and non-traditional applications. The growing demand for better sequencing-based diagnostics has fueled the development of novel sequencing technologies. As a result, demand for technologies like high-throughput sequencers and portable units has skyrocketed. The market for NGS-based RNA-seq is increasing due to a number of causes, including technological developments in RNA-seq products, the advantages of RNA-seq over microarray technology, rapid expansion in research activities, an increase in RNA-seq awards, and a high need for precision medicine.
Increasing R&D activities
Increased research activity, rising demand for precision medicine, and growing benefits of RNA-Seq In the projected period of 2022–2029, the increasing number of RNA-Seq grants is expected to boost the growth of the NGS-based RNA-sequencing market. Increasing levels of investment in cancer research as well as the agriculture sector, on the other hand, will propel the NGS-based RNA-sequencing market forward over the projection period.
Demand of NGS sequencing
The demand for next-generation sequencing technology increased dramatically after its launch. It is widely utilised in both traditional and non-traditional applications to obtain advanced and comprehensive genetic insights. The growing demand for enhanced sequencing-based diagnostics has fueled the development of brand-new sequencing technologies. As a result, equipment like robust high-throughput sequencers and portable units have exploded in popularity.
Browse a Detailed Summary of NGS-Based RNA-Sequencing Market Research Report @ https://www.databridgemarketresearch.com/reports/global-ngs-based-rna-sequencing-market
Technological advancements in sequencing platforms
Continuous advancements in sequencing technology have allowed for the development of efficient, portable, and easy-to-use NGS sequencers that give speedy and exact results while minimising turnaround times. As a result, leading companies are continually focused on investing in research activities for new product development to improve their positions in this high-growth industry.
- In May 2021, SEQuoia RiboDepletion Kit for NGS, developed by Bio-Rad Laboratories, Inc., removes unnecessary ribosomal RNA from the RNA-sequencing library and enhances test efficiency.
- In March 2022, Element Biosciences Inc. has released the Element AVITI System, a benchtop sequencer that provides an unmatched mix of performance, affordability, and flexibility. A benchtop NGS instrument and related consumables make up this system.
Some of the major players operating in the NGS-based RNA-sequencing market are:
- Illumina Inc. (US)
- Thermo Fischer Scientific Inc. (US)
- Oxford Nanopore Technologies plc (UK)
- Agilent Technologies, Inc. (US)
- BGI (China)
- PerkinElmer Inc. (US)
- QIAGEN (Germany)
- Eurofins Scientific (Luxembourg)
- Hoffmann-La Roche Ltd (Switzerland)
- Takara Bio Inc. (Japan)
- GENEWIZ, Inc. (US)
- Hamilton Company (US)
- Macrogen Inc. (South Korea)
- Zymo Research Corporation (US)
- Tecan Trading AG (Switzerland)
Global NGS-Based RNA-Sequencing Market Scope
Product and Service
- Sample Preparation Products
- Sequencing Platforms and Consumables
- Sequencing Services
- Data Analysis, Storage, and Management
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-molecule Real-time Sequencing
- Nanopore Sequencing
- Expression Profiling Analysis
- Small RNA Sequencing
- De Novo Transcriptome Assembly
- Variant Calling and Transcriptome Epigenetics
- Research and Academia
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Other End Users
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Organization: Data Bridge Market Research